• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2400061 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-03-01 China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd view
CYSB2200238 乙型肝炎人免疫球蛋白 human hepatitis B immunoglobulin Injection Biological Products(原15) Supplementary Application 2022-09-29 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CYSB2200071 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2022-03-10 Green Cross China Biological Products Co Ltd view
CYSB2101040 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-04-14 Shanxi Kangbao Biological Product Co Ltd view
CYSB2400198 乙型肝炎人免疫球蛋白 human hepatitis B immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-08-07 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CYSB2101161 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products Supplementary Application 2021-08-19 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CYSB2101138 乙型肝炎人免疫球蛋白 human hepatitis B immunoglobulin Injection Biological Products Supplementary Application 2021-08-10 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CYSB2200170 人免疫球蛋白 human immunoglobulin Injection Biological Products(原15) Supplementary Application 2022-07-14 Xinjiang Deyuan Biological Engineering Co Ltd view
CYSB2101072 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-05-24 Hualan Biological Engineering Inc view
CYSB2400253 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-09-26 Sinopharm Kunming Blood Products Co Ltd view
CYSB2300046 人免疫球蛋白 human immunoglobulin Injection Biological Products Supplementary Application 2023-02-22 Shandong Taibang Biological Products Co Ltd view
CYSB2400084 人免疫球蛋白 human immunoglobulin Injection Biological Products(原15) Supplementary Application 2024-03-29 Hualan Biological Engineering Inc view
CYSB2200240 静注人免疫球蛋白(10%) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-10-10 Guizhou Taibang Biological Products Co Ltd view
CYSB2200171 人免疫球蛋白 human immunoglobulin Injection Biological Products(原15) Supplementary Application 2022-07-14 Xinjiang Deyuan Biological Engineering Co Ltd view
CYSB2400277 静注人免疫球蛋白 human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-10-23 Hualan Biological Engineering Inc view
CYSB2300152 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products Supplementary Application 2023-08-19 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2101140 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products(原15) Supplementary Application 2021-08-10 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CYSB2200001 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products(原15) Supplementary Application 2022-01-05 Shandong Taibang Biological Products Co Ltd view
CYSB2400096 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CYSB2200072 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2022-03-10 Green Cross China Biological Products Co Ltd view